$ELTP

$0.26 -$0.00 (1.19%) Close

$ELTP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.08B shares outstanding

Who owns ELTP?

By type of holder

Institutions 0.0% Insiders 1.0% Everyone else 99.0%

Concentration Top 5 holders own 1.0%

Elite Pharmaceuticals Inc /NV/ 0.4% · Plassche Douglas 0.3%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

+500

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Kelleher Financial Advisors +500

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Elite Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2026

+34.8%

+3.37% a year

Each share's claim on the business

−25.8%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

50.0%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting ELTP on Form 13F

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
KF Kelleher Financial Advisors	1.0K	0.00%	+500 (+100.0%)		Q3 '25	0.0%
Shares held by quarter Peak holding1.0K (Q2'26) Change over 8 quarters+1.0K Share of the company0.000% Kelleher Financial Advisors's full portfolio →

Kelleher Financial Advisors

1.0K

% of company

0.00%

Change vs last qtr

+500 (+100.0%)

Held since

Q3 '25

Institutional Funds

Mutual funds and ETFs reporting ELTP on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
GC Gabelli Convertible & Income Securities Fund Inc Gabelli Convertible & Income Securities Fund Inc	$13.6K	200.0K	0.02%	0.01%	September 30, 2020

Gabelli Convertible & Income Securities Fund Inc

Position value

$13.6K

% of company

0.02%

% of the fund

0.01%

As of

September 30, 2020

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
EP Elite Pharmaceuticals Inc /NV/ Insider	4.3M	0.40%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.400% Elite Pharmaceuticals Inc /NV/'s insider activity →
PD Plassche Douglas Insider	3.5M	0.32%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.320% Plassche Douglas's insider activity →

Elite Pharmaceuticals Inc /NV/

Insider

4.3M

% of company

0.40%

Change vs last qtr

—

Held since

—

Plassche Douglas

Insider

3.5M

% of company

0.32%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Elite Pharmaceuticals Inc.

Comments